AI in Medicine News — 2026-10-28 (Wed) Daily News

Overview

Regulatory and commercial news centered on diagnostics: FDA clearance of AI chest CT software for aortic analysis and a CPT code for AI ECG heart attack detection (Diagnostic Imaging, VentureBeat). Studies of AI scribes reported shorter note-taking time but no clear productivity gain (MedPage Today, Bioengineer.org). Liability, trust and regulatory gaps for medical AI also drew coverage (Newsweek, Modern Healthcare News, The Clinical Trial Vanguard).

Diagnostics and imaging

- FDA cleared AI-enabled chest CT software for aortic analysis. The headline gives no product name or performance figures (Diagnostic Imaging). - Powerful Medical was granted a CPT code for AI ECG heart attack detection, weeks after FDA De Novo authorization of Queen of Hearts (VentureBeat). - Eulji University Medical Center is blending AI with 70 years of clinical expertise. The headline gives no performance data (Chosun Ilbo). - A federated AI framework pairs medical imaging accuracy with auditable explanations. The headline gives no figures and no stage of evidence (Bioengineer.org). - An AI system detects signs of pancreatic cancer more than a year before diagnosis. The headline gives no accuracy figures and no stage of evidence (SANA).

Clinical decision support

- A commentary asks whether AI inside the doctor's visit is helping or hunting for billable findings (The Clinical Trial Vanguard). - Vera Health has secured $28.5M for its clinical AI search platform (MobiHealthNews). - Machine learning may help predict diabetes in NAFLD. The headline gives no stage of evidence (EMJ). - A commentary argues that AI legal liability should be a red flag for health systems (Modern Healthcare News). - SGH's AI cuts brain bleed reporting time. The headline gives no figures (Healthcare IT News). 【Generative AI and medical documentation】 - A study found AI scribes improved note-taking time but not productivity (MedPage Today). - A report says an AI scribe trims note time for frequent users, but broader workload gains stay elusive (Bioengineer.org). - A pilot trial found that AI drafts with doctor oversight showed quality gains (Bioengineer.org). 【Hospital operations and care delivery】 - Healthcare AI ROI measurement is the subject of an article (HealthTech Magazine). - Articles discuss what changes for doctors and patients when AI enters the hospital (Unite.AI) and a roadmap for scaling agentic AI and physical AI in hospitals (World Health Expo (WHX)). - UT Austin unveiled UT Dell Medicine as it bets big on a new AI-native hospital (Fierce Healthcare). - A commentary says AI is a megaphone for bad data (Hospitalogy). 【Drug discovery and clinical trials】 No headline states a development stage (preclinical, Phase I, etc.). - An article says AI drug discovery is changing which experiments reach patients (Innovation News Network). - Parallel Bio appointed Jason Lew as Chief AI Officer to advance human-first drug discovery (citybiz). - Jones Day published a piece titled "AI Meets the Lab" (Jones Day). - A new US China investment proposal could reshape AI, biotech and chip funding (TechRepublic). - Anthropic laid out its drug R&D ambitions and risks in its IPO filing (Fierce Biotech). 【Medical device approval and regulation】 - Aortic analysis AI chest CT software: FDA clearance. The product name is not given (Diagnostic Imaging). - Queen of Hearts (Powerful Medical, AI ECG heart attack detection): FDA De Novo authorization. A CPT code, which is a billing code and not an approval, was granted weeks later (VentureBeat). - Agentic AI: an article explains why it is not yet FDA approved (Drug Topics). - Generative AI medical devices: Stanford scholars responded to the FDA on regulating them. The headline does not specify the type of FDA document (Freeman Spogli Institute for International Studies). - Heartflow sued AI rival Elucid over alleged IP violations. This is litigation, not a regulatory action (Cardiovascular Business). - An article covers what NHS trusts should set up now for AI medical device regulation after approval (Health Tech World). - AI adoption in clinical trials is slowed by regulatory gaps, not technology limits (The Clinical Trial Vanguard).

Safety, errors and bias

- Deutsche Telekom invested in Tandem Health, whose AI-powered medical assistant eases the burden on healthcare professionals (Deutsche Telekom). - An article says the liability battle over medical AI is coming (Newsweek). - UMich and European professors discussed AI in healthcare (The Michigan Daily). - Medical AI models that read images and write reports still face a trust gap (Bioengineer.org). - A headline reports 90% of AI medical alerts were ignored at Vanderbilt. The headline gives no study details (shattered.io). 【Research results (major journals)】 None of these headlines names a journal. - A Korean headline begins "Years earlier, a powerful artificial intelligence (AI) system was developed that could detect the in.." and is truncated, so its content cannot be determined (Maeil Business). - AI predicted a "death list" from single face analysis, with 50% of subjects having passed away within 90 days. The headline gives no study details (36Kr). - Medical AI systems outperformed doctors in clinical accuracy as Microsoft and Google validated MAI-DxO and AMIE, per the headline (Health Chosun). - Microsoft claims its new medical AI diagnostic orchestrator is better at diagnosing than real doctors. This is the company's claim (International Business Times UK). - An article covers how robotic surgery and AI in urology are transforming care, with the conundrum of costs (Il Sole 24 Ore).

Developments in Japan

- Fukushima Medical University, the Japan Diabetes Society and others are predicting future risk in diabetes patients using AI (CareNet.com). - Microsoft's diagnostic AI MAI-DxO reached an 83.2% correct diagnosis rate on difficult cases, and estimated costs were also lower under budget constraints, per the headline (Zaikei Shimbun). - In South Korea, a Samsung-affiliated hospital developed an AI robot as a surgical "assistant" (Nikkei). - Tairex announced MHAC, in which 54 AI doctors review cases alongside physicians (Pasquale Pillitteri). - A Japanese-language edition of the Unite.AI article on what changes for doctors and patients when AI enters hospitals was also published (Unite.AI).

Statements by key figures

No notable developments.